Musk Testifies in Lawsuit Against OpenAI, Seeks $134 Billion in Damages
Elon Musk has begun testifying in his case against OpenAI, seeking to remove leadership and claim $134 billion in damages over alleged contract violations.
Archives - Page 9
This page serves as the chronological archive of all MarketSpeaker content, organizing published material by date rather than topic or format. It aggregates news, briefs, guides, and other editorial outputs into a time-based structure, allowing readers to track coverage across specific periods. Designed for researchers, analysts, and returning readers, the archive provides a clear historical view of market narratives and reporting cycles. Unlike category or tag pages, it emphasizes temporal navigation over thematic grouping.
Select Year
Select Month
Wall Street Braces for Trillion-Dollar IPO Wave Led by SpaceX, OpenAI and Anthropic
A wave of potential trillion-dollar IPOs from SpaceX, OpenAI, and Anthropic is fueling market excitement and raising concerns over investor positioning.
Microsoft Loses OpenAI Exclusivity as Partnership Terms Shift
Microsoft will lose exclusive rights to OpenAI models, allowing broader distribution as the partnership evolves and revenue-sharing terms change.
U.S. Government’s Intel Stake Gains $25.7 Billion in Eight Months After CHIPS Investment
A U.S. government investment in Intel has generated $25.7 billion in unrealized gains in just eight months after shares surged following earnings.
China Blocks Meta’s $2 Billion Acquisition of AI Startup Manus
China has blocked Meta’s $2 billion acquisition of AI startup Manus, citing regulatory concerns over the cross-border deal.
SanDisk Shares Surge 3000% as AI Boom Drives Data Center Demand
SanDisk shares have surged 3000% over the past year as demand for AI data center storage fuels explosive growth.
Eli Lilly to Acquire Ajax Therapeutics in Deal Worth Up to $2.3 Billion
By Emma Clarke
Eli Lilly will acquire Ajax Therapeutics for up to $2.3 billion, strengthening its pipeline in blood cancer treatments.
Sun Pharma Shares Jump 7% on $11.75 Billion Organon Acquisition
By Emma Clarke
Sun Pharma shares rose 7% after announcing an $11.75 billion deal to acquire U.S.-based Organon, expanding its global footprint.
Microsoft Plans First Voluntary Buyouts Covering Up to 7% of U.S. Workforce
By Emma Clarke
Microsoft is introducing its first voluntary buyout program, targeting up to 7% of its U.S. workforce as part of broader efficiency efforts.
TSMC Shares Hit Record High as Taiwan Eases Investment Limits
TSMC shares reached a record high after Taiwan eased single-stock investment caps, boosting demand from institutional funds.